
1. Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. 
Print 2018 Feb.

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

Heyckendorf J(1)(2)(3), van Leth F(4), Kalsdorf B(5)(2)(3), Olaru ID(5)(6),
Günther G(7), Salzer HJF(5)(2)(3), Terhalle E(5)(2)(3), Rolling T(2)(8)(9),
Glattki G(10), Müller M(11), Schuhmann M(12), Avsar K(13), Lange C(5)(2)(3)(14).

Author information: 
(1)Division of Clinical Infectious Diseases, Research Center Borstel, Borstel,
Germany jheyckendorf@fz-borstel.de.
(2)German Center for Infection Research (DZIF), Germany.
(3)International Health/Infectious Diseases, University of Lübeck, Lübeck,
Germany.
(4)Dept of Global Health, Academic Medical Center, University of Amsterdam,
Amsterdam Institute for Global Health and Development, Amsterdam, The
Netherlands.
(5)Division of Clinical Infectious Diseases, Research Center Borstel, Borstel,
Germany.
(6)Dept of Microbiology, University Hospitals of Leicester, Leicester, UK.
(7)Dept of Medicine, University of Namibia School of Medicine, Windhoek, Namibia.
(8)Sections of Infectious Diseases and Tropical Medicine, I Dept of Internal
Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
(9)Clinical Research Unit, Bernhard-Nocht-Institute for Tropical Medicine,
Hamburg, Germany.
(10)Karl-Hansen-Klinik, Bad Lippspringe, Germany.
(11)Sankt Katharinen-Krankenhaus, Frankfurt, Germany.
(12)Thoraxklinik-Heidelberg, Heidelberg, Germany.
(13)Asklepios Fachkliniken München-Gauting, Munich, Germany.
(14)Dept of Medicine, Karolinska Institute, Stockholm, Sweden.

DOI: 10.1183/13993003.02122-2017 
PMID: 29467205  [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest: J. Heyckendorf has received
personal fees for lecturing at sponsored symposia from Chiesi, Gilead, Janssen
and Lucane, outside the submitted work. Conflict of interest: B. Kalsdorf has
provided independebt lectures for Lucane Pharma and Oxford Immunotec, outside the
submitted work. Conflict of interest: H.J.F. Salzer has received honoraria for
talks at scientific symposia organised by Chiesi and research grants from Gilead,
outside the submitted work. Conflict of interest: C. Lange has received personal 
fees for lecturing at sponsored symposia from Chiesi, Gilead, Abbvie, MSD, Becton
Dickinson, Janssen, Lucane, Novartis and Thermofisher, outside the submitted
work.

